Research from Frost & Sullivan indicates a strong comeback of IPOs suggesting a positive outlook for investment in the pharmaceutical and biotechnology industry.
FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.
DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.
The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.
GE Healthcare and Promosome sign a licensing agreement that gives GE Healthcare exclusive rights to a new suite of mammalian cell line development technologies.
Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.
Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.
Grace's ProVance disposable Protein A chromatography column is designed for downstream purification.
OPUS technology designed to process large single-use bioreactor harvests.
CBER will move to the FDA White Oak campus in Silver Spring, Maryland.